Unraveling the mystery of Gaucher bone density pathophysiology
Gaucher disease (GD) is caused by pathogenic mutations in GBA1, the gene that encodes the lysosomal enzyme β-glucocerebrosidase. Despite the existence of a variety of specific treatments for GD, they cannot completely reverse bone complications. Many studies have evidenced the impairment in bone tis...
Guardado en:
| Autores principales: | Rozenfeld, Paula Adriana, Crivaro, Andrea Natalia, Ormazabal, Maximiliano Emanuel, Mucci, Juan Marcos, Bondar, Constanza María, Delpino, María Victoria |
|---|---|
| Formato: | Articulo Preprint |
| Lenguaje: | Inglés |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/128409 |
| Aporte de: |
Ejemplares similares
-
In vitro osteoclastogenesis from Gaucher patients' cells correlates with bone mineral density but not with Chitotriosidase
por: Bondar, Constanza María, et al.
Publicado: (2017) -
Bone marrow adipocytes alteration in an in vitro model of Gaucher Disease
por: Crivaro, Andrea Natalia, et al.
Publicado: (2023) -
Bone Diseases as the only clinical manifestation of gaucher disease type
por: Guelbert, Norberto, et al.
Publicado: (2021) -
Exploring the pathophysiologic cascade leading to osteoclastogenic activation in gaucher disease monocytes generated via CRISPR/Cas9 technology
por: Ormazabal, Maximiliano Emanuel, et al.
Publicado: (2023) -
Osteocyte alterations induce osteoclastogenesis in an in vitro model of gaucher disease
por: Bondar, Constanza María, et al.
Publicado: (2017)